BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/27/2025 7:04:46 AM | Browse: 105 | Download: 552
 |
Received |
|
2025-02-04 19:31 |
|
Peer-Review Started |
|
2025-02-04 19:31 |
|
First Decision by Editorial Office Director |
|
2025-03-21 07:59 |
|
Return for Revision |
|
2025-03-21 07:59 |
|
Revised |
|
2025-03-31 15:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-04-22 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-04-22 10:45 |
|
Articles in Press |
|
2025-04-22 10:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-14 02:36 |
|
Publish the Manuscript Online |
|
2025-05-27 07:04 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sahana Shetty, Renuka Suvarna, Vanessa Ambrose Fistus, Shivam Modi and Joseph M Pappachan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, MD, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, Manchester, Manchester M15 6BH, Please enter the state or province, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Cardiovascular disease; Cardiovascular events; Insulin resistance; Metabolic dysfunction-associated fatty liver disease; Type 2 diabetes mellitus. |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease (MAFLD) and type 2 diabetes mellitus (T2DM) are independent risk factors for the development of cardiovascular disease (CVD) with an exaggerated risk of cardiovascular events (CVE) when both diseases co-exist. A systematic review of fourteen studies with 370013 participants showed that the risk of CVE in T2DM was higher in the MAFLD group when compared to the non-MAFLD group [odds ratios (OR): 1.28] with follow up duration ranging between 5-6 years. The prevalence of CVD was higher (OR: 1.47) in T2DM with MAFLD when compared to T2DM without MAFLD. In conclusion, presence of MAFLD in T2DM increased the risk of CVE and CVD as compared to T2DM without MAFLD. |
| Publish Date |
2025-05-27 07:04 |
| Citation |
Shetty S, Suvarna R, Ambrose Fistus V, Modi S, Pappachan JM. Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis. World J Hepatol 2025; 17(5): 105706 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i5/105706.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i5.105706 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
